Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question.

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question. Arterioscler Thromb Vasc Biol. 2013 Mar; 33(3):447-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.